欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2007, Vol. 12 ›› Issue (12): 1381-1388.

• 基础研究 • 上一篇    下一篇

阿托伐他汀对心肌梗死后大鼠转化生长因子–β1和白介素–lβ转录水平的影响

王艾丽1, 陈玲玲2, 胡剑峰1, 程新耀1   

  1. 1武汉大学中南医院超声心动图室,武汉 430071,湖北;
    2麻城市妇幼保健院儿科,麻城 438300,湖北
  • 收稿日期:2007-08-20 修回日期:2007-11-23 发布日期:2020-11-10
  • 作者简介:王艾丽,女,硕士,主管技师,研究方向:冠心病基础与临床。TeI:027-63633670 E-mail:wangal07@126.com

Effects of atorvastain on transcription levels of TGF-β1 and IL-lβ in rats post myocardial infarction

WANG Ai-li1, CHENG Ling-ling2, HU Jian-feng1, CHENG Xin-yao1   

  1. 1Department of Ultrasoundcardiogram, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China;
    2Department of Pediatrics, Miacheng Maternity and Children's Hospital, Macheng 438300, Hubei, China
  • Received:2007-08-20 Revised:2007-11-23 Published:2020-11-10

摘要: 目的: 探讨心肌梗死后细胞转化生长因子-β1(TGF-β1)和白介素-I3(IL-1β)的转录水平以及阿托伐他汀对其的影响。方法: 结扎冠脉左前降支造成急性心梗模型,随机分为心肌梗死组和阿托伐他汀治疗组,每组21只,另设13只为假手术组。阿托伐他汀治疗组于手术后2d起灌胃给药,心肌梗死组和假手术组只给予等量清水灌胃。第1周后各组取3只大鼠检测TGF-P和IL-1βmRNA的转录水平变化;第6周后行超声心动图、心室重塑、TGF-β1和IL-Iβ mRNA的测定。结果: 与心肌梗死组相比,阿托伐他汀治疗组左室舒张末期内径(LVEDD)及左、右心室肥厚指数降低;短轴缩短率(FS)和左室射血分数(EF)均增加(P < 0.05);心肌梗死后第1周心肌梗死组和阿托伐他汀治疗组梗死区周边TGF-β1和IL-|β mRNA的转录较假手术组有不同程度增高(P < 0.05)。梗死后第6周心肌梗死组IL-1β mRNA的转录与第1周相比有明显降低,而TGF-β1 mRNA仍呈高转录水平(P < 0.05);与假手术组相比两细胞因子仍增高(P < 0.05)。梗死后第6周阿托伐他汀治疗组IL-1β和TGF-β1 mRNA的表达较第1周相比皆降低(P < 0.05);与心肌梗死组相比也降低(P < 0.05)。结论: 阿托伐他汀能降低急性心梗大鼠心肌TCF-3和IL-1β转录水平,减轻心室重塑,改善心功能。

关键词: 过肌梗死, 心室重塑, 转化生长因子–β1, 白介素–1β, 阿托伐他汀

Abstract: AIM: To investigate the effects of atorv-astain on transcription levels of cytokines of TGF-β,andIL-1ppost acute myocardial infarction in rats. METH-ODS: Rats with acute myocardial infarction were random-ly divided into myocardial infarction group and'atorvastaintreatment group(21 in each group). 13 normal rats wereused as non-infarction controls(sham group). In treat-I ment group,atorvastain wasintragastrically administra-tered at the 2 nd day after myocardial infarction. After 1week, TGF-β, and IL-1β mRNA were detemined in eachgroup. After 6 weeks, the cardiac function, related ven-tricular remodeling parameters and TGF-β and IL-1β mR-NA were determined as well. RESULTS: Compared withmyocardial infarction group, atorvastain significantly de-creased LV end-diastolic dimension (LVEDD). However,the ventricular remodeling parameters, ejection fraction(EF) and fractional shortening (FS) weresignificantly increased in atorvastain treatment group, compared withmyocardial infarction group (P < 0.05). The mRNAtranscription levels of TGF-β, and IL-lβ in both myocardi-al infarction and atorvastain treatment groups were signifi-cantly higher than those in the sham group (P < 0.05).After 6 weeks, IL-1β and TGF-β mRNA levels were in-creased in myocardial infarction group. After treatmentwith atorvastain for 6 weeks, the mRNA levels of IL-1β and TGF-β were decreased compared with myocardial in-farction group(P < 0.05). CONCLUSION: Atorvastaincandownregulate TGF-β, and IL-1β transcription and maybe effetive in preventingventricular remodeling aftermyocardial infarction in rats.

Key words: Smyocardial infarction, ventricular re-modeling, TGF-β, IL-1β, atorvastain

中图分类号: